CDKN2A Alterations and Response to Immunotherapy in Solid Tumors.

Elio AdibAmin H NassarElie W AklSarah Abou AlaiwiPier Vitale NuzzoTarek H MouhieddineGuru SonpavdeRobert I HaddadKent W MouwMarios GiannakisF Stephen HodiSachet A ShuklaAlexander GusevDavid A BraunToni K ChoueiriDavid J Kwiatkowski

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)

Our data show that CDKN2A GAs were associated with reduced benefit from ICI therapy in urothelial carcinoma as well as changes in the tumor-immune microenvironment.

Keyphrases

stem cells
electronic health record
big data
room temperature
cell therapy